Wordt geladen...
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
With the recent FDA approval of the first siRNA-derived therapeutic, RNA interference (RNAi)-mediated gene therapy is undergoing a transition from research to the clinical space. The primary obstacle to realization of RNAi therapy has been the delivery of oligonucleotide payloads. This review aims t...
Bewaard in:
| Gepubliceerd in: | Adv Mater |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6891135/ https://ncbi.nlm.nih.gov/pubmed/31566258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.201903637 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|